Industry News
Academic Research
Peptide Article Directory
- Good news! shengnuo biotechnology-Octreotide Acetate Injection won the bid in the national centralized drug procurement
- CStone Pharmaceuticals completes the first patient enrollment in Phase I clinical trials in the United States for the treatment of advanced B-cell lymphoma and solid tumors
- shengnuo biotechnology: Fertility drug “Atosiban Acetate Injection” passed the consistency evaluation of generic drugs
- shengnuo biotechnology: Subsidiary Octreotide Acetate API was certified by the European Medicines Agency
- eptifibatide injection
- somatostatin for injection
- shengnuobiotechnology has been investigated by 3 institutions: the peptide API segment is the company’s key development segment. This business has grown rapidly in the past two years. After the completion of the capacity expansion, it is expected to bring further profit growth to the company.
- peptide api manufacturing peptide company peptide manufacturer peptide medicine peptide order peptide preparation peptide product peptide production peptide services
- Good news! shengnuo Bio-Octreotide Acetate Injection won the bid in the national centralized drug procurement!
- Under the adverse economic environment,shengnuo biotechnology one-year growth interview and broadcast article listed on the Science and Technology Innovation Board
- Moving forward in the face of economic adversity, the first anniversary of shengnuo biotechnologylisting!
- Review the old and learn the new, nostalgia and gratitude丨Let us continue to move forward and create great achievements
- One specialization and multiple functions, the industrial value ofshengnuo biotechnology with peptides as the core is not only the exchange of time for space
- shengnuo biotechnology 2021 Annual Report Released! Innovation + medical beauty double layout, committed to new growth
- shengnuo biotechnology 2021 performance will grow steadily and will accelerate the pace of R&D innovation and internationalization Broadcast article
- shengnuo biotechnology will see double growth in revenue and net profit in 2021 and enter the cosmetics business
- shengnuo biotechnology: Deepening the Development of CDMO Industry Chain Three Outward Investments Expand Growth Space Broadcast Article
- shengnuo biotechnology announced the quarterly report for the first quarter of 2022, actively promoting the layout of peptide medical beauty
- Anti-epidemic welcome new army! Shengnuo Biological has obtained the exclusive right to use the patent and will broadcast the article on the development of new crown peptide drugs
- Anti-epidemic welcome new army! shengnuo Bio has obtained the exclusive right to use the patent and will broadcast the article on the development of new crown peptide drugs
- Exchange links with you on my site, or help out with press releases or blog posts.
- 2022 The peptide drug market has broad prospects, but it still faces 3 major challenges
- The “beauty peptide” skin care product boom is coming! What magic does it have? Broadcast article
- palmitoyl tetrapeptide-7–Custom manufactured peptides
- 2022 peptide APIs product list and the best peptide company
- I want to buy peptide raw materials, how to choose a good company?
- This article understands the reason behind the CXO track players’ layout of peptides Peptide drugs have a wide range of applications and development prospects
- What are the uses of polypeptide drugs, let’s find out together!
- Polypeptide CDMOs: shengnuo Biological
- shengnuo biotechnology: The domestic peptide drug manufacturer with the whole industry chain layout broadcasts the article
- Shengnuo biotechnology: 11 institutions including Tianfu Hedge Fund Institute and Jinfeng Yinfan investment investigated our company on December 14
- About Peptide C China DMO
- Founded in July 2001, Chengdu Shengnuo Biotechnology Co., Ltd. has advanced and efficient peptide drug technology R & D and large-scale production capacity.
- Promote development, improve together, Shengnuo Biology——Help the 7th Polypeptide Frontier Technology Academic Exchange Conference
- shengnuo biotechnology: As of June 30, 2021, the company has 32 authorized invention patents, 9 utility model patents, and 2 international PCT broadcast articles
- This article understands the behind the CXO track players are deploying peptides. Peptide drugs have a wide range of applications and bright development prospects.
- The rising trend is swift, and the third quarter report of 2021 of shengnuo biotechnology discloses that the net profit attributable to the mother has increased by 83.9%.
- Peptide drugs open up the blue ocean in the anti-infection market, antimicrobial peptide blockbuster drugs are highly anticipated
- shengnuo biotechnology: Leading domestic peptide drug company Net profit attributable to the parent rose 83.9% in the third quarter
- Peptide whole industry chain advantage is outstanding Shengnuo Bio’s new project will quickly relieve the capacity bottleneck Podcast Article
- shengnuo biotechnology: The company’s CDMO service orders have gradually entered the review stage
- Interpretation of Semi-annual Report｜shengnuo biotechnologytechnology H1 increases revenue but does not increase profit Q3 new projects are put into use, it is expected to alleviate the bottleneck of production capacity
- Forecast of the development prospects and investment feasibility assessment analysis report of the peptide drug industry in 2021
- shengnuo biotechnology focuses on the field of peptide APIs and preparations
- shengnuo biotechnologynology meets at the 2nd China Peptide Industry Forum to seek new opportunities for industry development
- The saints are outstanding, and Nuo creates brilliance. The 20th anniversary celebration and thank you dinner of shengnuo biotechnology come to a successful conclusion
- Co-casting “peptides” is wonderful, shengnuo biotechnology was invited to participate in the 2nd China Polypeptide Industry Forum
- Who will make the first shot in the 350 billion antimicrobial peptide market under the rise of peptide drugs?
- shengnuo biotechnology meets at the 2nd China Peptide Industry Forum to seek new opportunities for industry development
- shengnuo biotechnology: In the future, the company will seize the development opportunities of the rapid growth of the peptide generic drug market and continue to deepen the peptide drug market
- What are the similarities and differences between shengnuo biotechnology companies + CDMO companies? Who has more potential in the future?
- Analysis of China’s peptide drug market scale and industry development trend in 2021
- Shengnuo Biotechnologynology focuses on the field of peptide APIs and preparations
- Shengnuo Biotechnologytechnology IPO: Peptide CDMO has outstanding competitive advantages, product line covers multiple fields
- Shengnuo Biotechnologytechnology Science and Technology Innovation Board is listed to strengthen the two-way competitive advantage of peptide innovative drug pharmaceutical research services and independent peptide drug products
- Opened up 352.51%, peptide drug R&D company Shengnuo Biotechnology listed on the Science and Technology Innovation Board today
- What is the application of peptides in the diagnosis and treatment of lung cancer
- From the perspective of market distribution, there are more than 40 peptide drugs on the market in my country, which are mainly distributed in seven fields, including immunity, digestive tract, anti-tumor, orthopedics, obstetrics, diabetes and cardiovascular. Among them, immune drugs dominate, accounting for more than 50% of the domestic market
- Based on the market research of peptide drugs in the above-mentioned therapeutic fields, the company carefully selects 2-3 peptide drugs in each field for echelon research and development.
- Peptide is a compound formed by linking multiple amino acids together by peptide bonds
- shengnuo biotechnology, a leading company in the field of peptide drug research and development in China
- The market share exceeds 20%! The leader of oxytocin medicine hits the science and technology innovation board and cooperates with more than a thousand public hospitals
- shengnuo biotechnology focuses on the field of peptide APIs and preparations
- Shengnuo Biotech: plans to publicly issue 20 million shares and will actively deploy peptide innovative drug business areas
- Shengnuo Biotech: A professional peptide drug manufacturer with significant R&D advantages and a full industrial chain layout
- Shengnuo Biotech will participate in the 2021 China Pharmaceutical CMC Industry Chain Summit Forum to seek high-quality development of the industry
- Shengnuo Biotechnology: The layout of the whole industry chain One of the most powerful peptide drug synthesis and production platforms in China
- Speech by Mr. Wen Yongjun, Chairman and General Manager of Chengdu Shengnuo Biotechnology Co., Ltd.
- Purchase today: Shengnuo Biotechnology, Happy Home, Pulian Software
- Peptides and Your Skin Care Routine
- What Are Peptides?
- Hair growth material blue copper peptide AHK-Cu /AHK copper introduction Copper Peptide (copper peptide) is a complex of AHK tripeptide and divalent copper ion, used for skin anti-wrinkle repair and firming hair growth.
- Oligopeptide-10 (oligopeptide-10)-is an antibacterial peptide used to treat acne symptoms
- palmitoyl pentapeptide-3
- The role and efficacy of palmitoyl tripeptide-5
- Water-soluble cosmetic raw materials-solubility classification of peptides
- The real acetyl hexapeptide-8 (hexapeptide) is like this
- The role of polypeptides in cosmetics The biological activity of polypeptides depends on their amino acid composition and sequence.
- The latest anti-fatigue peptide: Poly(Tripeptide-6)-Awakening Peptide
- The freeze-dried powder is made by dissolving the peptide components at a low temperature in a sterile environment, and then placed in a vacuum environment.
- Palmitoyl Pentapeptide-4
- Epidermal Growth Factor Substitute–Thirteen Peptide-1
- Common misunderstandings in the use of cleaning products:
- Pro-tested anti-wrinkle baby-Acetyl Hexapeptide- Acetyl Hexapeptide-8
- Peptide APIs CASE
- CASE
- Mao gave up treatment? -Myristoyl pentapeptide-17
- Pro-test wrinkle removal artifact-Acetyl Hexapeptide-8/Akirelin
- Conotoxin is a biologically simulated conotoxin peptide, which is sorted and artificially synthesized to provide a very powerful muscle relaxation effect and provide a rapid and immediate anti-wrinkle effect.
- As a professional supplier of cosmetic peptide raw materials in China, it has successfully developed more than 100 kinds of cosmetic active peptide raw materials
- The two most commonly used anti-wrinkle peptides: Acetyl Hexapeptide-8 and dipeptide
- A cosmetic peptide material for enhancing skin defenses, controlling oil and acne Acetyl dipeptide-3 aminocaproate
- Copper peptide
- Copper Peptide has both skin repair and hair growth enhancement effect.
- Professional Beauty Peptide Company in China
- Why did China’s synthetic bovine insulin miss the Nobel Prize in the last century?
- Anti-aging cosmetic peptides
- Anti-ultraviolet cosmetic peptide
- Slimming and breast enhancement cosmetic peptides
- Cosmetic peptides for removing bags under the eyes and dark circles under the eyes
Other Polypeptide APIs Products
peptide synthesis companies
| Polypeptide APIs Products |
| US-DMF LIST |
| Beauty peptides |
| Chinese cGMP APIs |
| Mexico Registered APIs |
| Research Peptide APIs for Regulatory Market |
| Polypeptide Preparation |
| Kaijie bio medicine Peptide APIs |
How many companies are there in peptide api manufacturer in china? The peptide api market is very promising, and the world is encouraging the development of peptide business. There is a peptide api list on the website Biofda.com, which contains various specifications of peptide APIs for customers to choose from. Shengnuo Technology is a peptide api manufacturer located in Chengdu, a city in southwest China. Not only peptide APIs, but also carnosine custom suppliers and cosmetic peptide suppliers
There are many peptide apis manufacture in China, but they are all small-scale companies. The China peptide company such as Sinotech is a leading company in China and has a very high position.
As a Chinese peptide company, Sinotech has been working silently, hoping to become a top peptide company in the world. There are many countries producing peptides in the world, such as bulk drug substance in India, gmp custom peptide in uk, and peptide production in usa. So what is polypeptide? What kind of peptide synthesis supplier should you choose? Follow our website: www.biofda.com, here will tell you the answer.
English
Arabic
Dutch
French
German
Italian
Japanese
Latin
Portuguese
Russian
Spanish